Bunor: Pathways for pharmaceutical interventions to markets key

In a recent interview with CNBC Africa, Peter Bunor Junior, the Co-Founder of Field Intelligence, emphasized the importance of building pathways for new and existing pharmaceutical interventions directly to markets to enhance healthcare access. Bunor noted that supply chains are a crucial intersection of technology, information, and money. The company's routed market service aims to bridge the gap between developed markets with abundant medical commodities and regions like Nigeria and the African continent where essential drugs are scarce. By creating a robust infrastructure, including distribution networks, regulatory approvals, and market entry strategies, Field Intelligence strives to ensure that life-saving medications reach end-users such as hospitals, pharmacies, and government health facilities. The Gates Foundation's support of $11 million has enabled the company to focus on maternal mortality, newborn and child health, and nutrition. This funding has allowed Field Intelligence to enhance its route to market service, ensuring the availability of essential commodities and building necessary infrastructure like coaching, equipment support, and digital systems for monitoring and tracking. Bunor highlighted the pivotal role of digitization in driving efficiency and optimizing supply chains. By leveraging intelligent platforms and data analytics, Field Intelligence can make informed decisions, prevent stockouts, and enhance overall healthcare delivery. The company's approach involves a combination of software solutions for managing public health systems and physical logistics to distribute medications across various healthcare providers. Operating in Nigeria and Kenya, Field Intelligence plans to expand its operations to other African countries by carefully evaluating market size, need, and healthcare system dynamics.